Session » (1855–1876) Systemic Sclerosis & Related Disorders – Basic Science Poster II
- 10:30AM-12:30PM
-
Abstract Number: 1869
A miRNA signature consisting of high Let7i-5p, high miR-483-5p, low miR-223- 3p characterizes connective tissue diseases with interstitial lung disease
- 10:30AM-12:30PM
-
Abstract Number: 1861
Accelerated and Gene-Specific Patterns of Clonal Hematopoiesis Distinguish Subtypes of Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1858
Antinuclear Antibodies from Systemic Sclerosis Patients Enter Cells via a Clathrin Endocytosis Mechanism and Interact with their Intracellular Antigen.
- 10:30AM-12:30PM
-
Abstract Number: 1863
Bag3 in systemic sclerosis: possible therapeutic target and biomarker for pulmonary fibrosis
- 10:30AM-12:30PM
-
Abstract Number: 1862
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis-associated interstitial lung disease identifies novel associated loci and potential progression biomarkers
- 10:30AM-12:30PM
-
Abstract Number: 1867
Deciphering the Molecular Landscape of the Small Intestine in Early and Late SSc Using High-Definition Spatial Transcriptomics
- 10:30AM-12:30PM
-
Abstract Number: 1866
Elucidating gastric pathology in systemic sclerosis using single-cell RNA sequencing
- 10:30AM-12:30PM
-
Abstract Number: 1871
Examining the impact of ETV2 on altered endothelial phenotype in systemic sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1875
Fcγ-receptor activation by circulating immune complexes in autoimmunity and CD19.CAR-T cell therapy
- 10:30AM-12:30PM
-
Abstract Number: 1868
Global Downregulation of Fli1 in Mice Induces Cardiac Dysfunction via Enhanced β-fatty acid Oxidation and Collagen Deposition
- 10:30AM-12:30PM
-
Abstract Number: 1860
GLUT and FAPα as molecular imaging markers for interstitial lung disease in systemic sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1872
High-throughput Screening Uncovers Distinct Molecular Signatures Linked with HRCT Patterns in SARD-ILD
- 10:30AM-12:30PM
-
Abstract Number: 1864
Mitochondrial Dysfunction Drives cGAS-STING–Mediated Type I Interferon Production and Fibrosis in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1874
Neutrophil Extracellular Trap-Rich Systemic Sclerosis Plasma Promotes Microvascular Endothelial Cell Proliferation and Migration: Implications for Aberrant Angiogenesis
- 10:30AM-12:30PM
-
Abstract Number: 1870
Paracrine WNT Signaling Modulates Profibrotic Macrophage Metabolic Activation in Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 1857
Role of autoantigen-specific reactivity in the pathogenesis of murine interstitial lung disease model with anti-MDA5 antibody mouse model
- 10:30AM-12:30PM
-
Abstract Number: 1865
Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multi-omics analysis
- 10:30AM-12:30PM
-
Abstract Number: 1855
Small Bowel Microbial Dysbiosis and Impaired Intestinal Absorptive Function in Systemic Sclerosis- A Single Center Prospective Study
- 10:30AM-12:30PM
-
Abstract Number: 1856
Spatial Proteomic-based Phenotyping of Fibroblast Populations and their Microenvironment in Systemic Sclerosis Primary Heart Involvement
- 10:30AM-12:30PM
-
Abstract Number: 1876
Targeting the NK cell checkpoint NKG2A promotes lung fibrosis resolution by enhancing immune clearance of senescent myofibroblasts
- 10:30AM-12:30PM
-
Abstract Number: 1873
TGF-β-Driven Mitochondrial Stress Activates cGAS-STING Signalling via Impaired Mitophagy in Systemic Sclerosis Endothelial Cells